Researchers have mapped a previously unseen drug-binding pocket on PKMYT1, a kinase tied to cancer cell division, using X-ray ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...

Many modern cancer treatments, including immunotherapy, depend on activating killer T cells to recognise and destroy tumours.

A new era in the treatment of deadly pancreatic cancer was heralded by scientists this week, thanks to research by the ...

Lung cancer is often called the silent killer. By the time symptoms appear, the disease has usually advanced, making ...

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

Young colon cancer may not be not the same disease doctors are used to treating. Researchers are discovering new links to ...

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were ...

Louise van der Weyden is a dog person. But as a scientist who studies cancer in animals, she has turned her attention to cats ...

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...

Be brave, be bold, and challenge the status quo.” Those were words spoken by renowned melanoma researcher professor Richard ...

Cancer research this year reshaped how scientists understood, detected, and treated the disease. Researchers figured out how viral infections could reawaken dormant cancer cells, leveraged lessons ...